Corbus Pharmaceuticals Holding Stock Price History
| CRBP Stock | USD 6.90 0.50 6.76% |
Below is the normalized historical share price chart for Corbus Pharmaceuticals Holding extending back to October 27, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Corbus Pharmaceuticals stands at 6.90, as last reported on the 1st of July, with the highest price reaching 7.43 and the lowest price hitting 6.85 during the day.
If you're considering investing in Corbus Stock, it is important to understand the factors that can impact its price. Corbus Pharmaceuticals appears to be moderately volatile, given 3 months investment horizon. Corbus Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. By analyzing Corbus Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please makes use of Corbus Pharmaceuticals' Downside Deviation of 4.9, mean deviation of 4.07, and Risk Adjusted Performance of 0.1221 to double-check if our risk estimates are consistent with your expectations. At this time, Corbus Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 07/01/2025, Common Stock Shares Outstanding is likely to grow to about 11.5 M, while Stock Based Compensation is likely to drop slightly above 5.7 M. . Corbus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of November 2014 | 200 Day MA 12.8024 | 50 Day MA 7.6902 | Beta 3.117 |
Sharpe Ratio = 0.1135
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CRBP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.31 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.6 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Corbus Pharmaceuticals is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corbus Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.6643 | Enterprise Value Ebitda 0.1697 | Price Sales 163.3187 | Shares Float 7.5 M | Wall Street Target Price 42.8889 |
Corbus Pharmaceuticals Stock Price History Chart
There are several ways to analyze Corbus Stock price data. The simplest method is using a basic Corbus candlestick price chart, which shows Corbus Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 10, 2025 | 9.24 |
| Lowest Price | April 3, 2025 | 4.92 |
Corbus Pharmaceuticals July 1, 2025 Stock Price Synopsis
Various analyses of Corbus Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Corbus Stock. It can be used to describe the percentage change in the price of Corbus Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Corbus Stock.| Corbus Pharmaceuticals Accumulation Distribution | 25,768 | |
| Corbus Pharmaceuticals Price Daily Balance Of Power | (0.86) | |
| Corbus Pharmaceuticals Price Rate Of Daily Change | 0.93 | |
| Corbus Pharmaceuticals Price Action Indicator | (0.49) |
Corbus Pharmaceuticals July 1, 2025 Stock Price Analysis
Corbus Stock Price History Data
The price series of Corbus Pharmaceuticals for the period between Wed, Apr 2, 2025 and Tue, Jul 1, 2025 has a statistical range of 4.32 with a coefficient of variation of 16.71. The prices are distributed with arithmetic mean of 7.17. The median price for the last 90 days is 7.39. The company had 1:30 stock split on 14th of February 2023.| Open | High | Low | Close | Volume | ||
| 06/30/2025 | 7.32 | 7.43 | 6.85 | 6.90 | 330,101 | |
06/27/2025 | 7.98 | 8.05 | 7.40 | 7.40 | 1,390,716 | |
06/26/2025 | 8.67 | 8.70 | 7.72 | 8.02 | 160,323 | |
| 06/25/2025 | 8.01 | 8.71 | 7.81 | 8.67 | 243,793 | |
| 06/24/2025 | 7.88 | 8.08 | 7.82 | 7.96 | 146,254 | |
06/23/2025 | 8.19 | 8.20 | 7.66 | 7.89 | 105,026 | |
06/20/2025 | 8.40 | 8.53 | 8.12 | 8.24 | 135,432 | |
06/18/2025 | 8.28 | 8.47 | 8.10 | 8.31 | 68,116 | |
06/17/2025 | 8.70 | 8.71 | 8.28 | 8.28 | 102,099 | |
06/16/2025 | 8.87 | 9.14 | 8.62 | 8.74 | 85,535 | |
06/13/2025 | 8.98 | 9.15 | 8.80 | 8.83 | 98,376 | |
06/12/2025 | 8.90 | 9.28 | 8.56 | 9.17 | 118,603 | |
06/11/2025 | 9.30 | 9.39 | 8.97 | 8.97 | 137,016 | |
06/10/2025 | 9.26 | 9.40 | 9.02 | 9.24 | 157,953 | |
06/09/2025 | 9.24 | 9.45 | 8.86 | 9.21 | 152,249 | |
06/06/2025 | 8.99 | 9.35 | 8.90 | 9.23 | 151,636 | |
06/05/2025 | 8.51 | 8.85 | 8.10 | 8.80 | 169,998 | |
06/04/2025 | 8.29 | 8.53 | 8.02 | 8.47 | 163,821 | |
| 06/03/2025 | 7.40 | 8.36 | 7.22 | 8.30 | 236,105 | |
06/02/2025 | 7.46 | 7.56 | 7.05 | 7.34 | 106,693 | |
| 05/30/2025 | 7.58 | 7.58 | 7.18 | 7.42 | 94,412 | |
05/29/2025 | 7.29 | 7.62 | 7.05 | 7.62 | 123,047 | |
05/28/2025 | 7.38 | 7.44 | 7.17 | 7.23 | 92,611 | |
05/27/2025 | 7.52 | 7.72 | 7.21 | 7.36 | 112,726 | |
05/23/2025 | 7.36 | 7.57 | 7.28 | 7.40 | 79,672 | |
| 05/22/2025 | 7.39 | 7.67 | 7.34 | 7.54 | 84,306 | |
05/21/2025 | 7.45 | 7.55 | 7.16 | 7.41 | 107,144 | |
05/20/2025 | 7.80 | 8.12 | 7.44 | 7.57 | 174,097 | |
| 05/19/2025 | 7.32 | 8.08 | 7.10 | 7.76 | 197,240 | |
05/16/2025 | 7.27 | 7.41 | 7.22 | 7.34 | 65,489 | |
05/15/2025 | 7.03 | 7.28 | 6.80 | 7.21 | 60,053 | |
05/14/2025 | 7.29 | 7.44 | 6.76 | 7.04 | 94,269 | |
05/13/2025 | 7.21 | 7.44 | 6.91 | 7.26 | 130,893 | |
05/12/2025 | 6.80 | 7.17 | 6.53 | 7.16 | 138,491 | |
05/09/2025 | 6.65 | 6.91 | 6.33 | 6.45 | 126,377 | |
| 05/08/2025 | 6.30 | 6.88 | 6.25 | 6.65 | 130,572 | |
| 05/07/2025 | 6.57 | 6.57 | 6.10 | 6.13 | 127,994 | |
05/06/2025 | 7.30 | 7.30 | 6.20 | 6.25 | 179,277 | |
05/05/2025 | 7.70 | 7.78 | 7.40 | 7.42 | 83,657 | |
05/02/2025 | 7.57 | 8.07 | 7.40 | 7.79 | 91,676 | |
05/01/2025 | 7.45 | 7.91 | 7.20 | 7.52 | 147,179 | |
04/30/2025 | 7.16 | 7.60 | 6.92 | 7.47 | 132,044 | |
04/29/2025 | 7.40 | 7.40 | 7.00 | 7.20 | 123,163 | |
04/28/2025 | 8.15 | 8.26 | 7.11 | 7.50 | 147,280 | |
04/25/2025 | 8.57 | 8.73 | 7.92 | 8.08 | 226,008 | |
04/24/2025 | 7.35 | 8.47 | 7.35 | 8.35 | 268,516 | |
04/23/2025 | 6.87 | 7.47 | 6.83 | 7.39 | 209,995 | |
04/22/2025 | 6.30 | 6.84 | 6.26 | 6.69 | 175,562 | |
04/21/2025 | 5.96 | 6.36 | 5.90 | 6.30 | 107,184 | |
04/17/2025 | 5.89 | 6.14 | 5.78 | 6.03 | 121,749 | |
04/16/2025 | 5.96 | 6.03 | 5.75 | 5.92 | 138,117 | |
04/15/2025 | 5.78 | 6.02 | 5.73 | 5.99 | 118,927 | |
04/14/2025 | 6.15 | 6.29 | 5.68 | 5.80 | 122,387 | |
| 04/11/2025 | 5.71 | 6.17 | 5.69 | 6.04 | 221,970 | |
04/10/2025 | 5.55 | 5.75 | 5.32 | 5.69 | 126,286 | |
04/09/2025 | 5.30 | 5.99 | 5.23 | 5.67 | 307,949 | |
04/08/2025 | 5.38 | 5.68 | 5.12 | 5.39 | 297,795 | |
04/07/2025 | 4.83 | 5.23 | 4.64 | 5.21 | 245,489 | |
04/04/2025 | 4.75 | 5.04 | 4.68 | 5.02 | 204,600 | |
04/03/2025 | 5.20 | 5.20 | 4.67 | 4.92 | 224,587 | |
04/02/2025 | 4.92 | 5.30 | 4.92 | 5.20 | 164,330 |
About Corbus Pharmaceuticals Stock history
Corbus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corbus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corbus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corbus Pharmaceuticals stock prices may prove useful in developing a viable investing in Corbus Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 10.9 M | 11.5 M | |
| Net Loss | -38.1 M | -40 M |
Corbus Pharmaceuticals Stock Technical Analysis
Corbus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Corbus Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Corbus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Corbus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corbus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1221 | |||
| Jensen Alpha | 0.3065 | |||
| Total Risk Alpha | 0.1639 | |||
| Sortino Ratio | 0.0606 | |||
| Treynor Ratio | 0.4264 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Corbus Stock Analysis
When running Corbus Pharmaceuticals' price analysis, check to measure Corbus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corbus Pharmaceuticals is operating at the current time. Most of Corbus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corbus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corbus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corbus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.